⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL801212 | 1.00 | — | — | |
| SCHEMBL238192 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL3943090 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL238191 | 0.97 | — | — | |
| Bromide SCHEMBL10783307 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2785010 | 0.97 | — | — | |
| Trifluoroacetic Acid SCHEMBL8326752 | 0.84 | CA14 (0.42) | — | |
| Trifluoroacetic Acid SCHEMBL8326750 | 0.84 | CA14 (0.42) | — | |
| SCHEMBL12890766 | 0.83 | CA14 (0.45) | — | |
| SCHEMBL9947502 | 0.83 | CA14 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116273432-A | Beneficiation method for comprehensively recovering rubidium from hard rock type lithium multi-metal ore | 广东省科学院资源利用与稀土开发研究所 | 2023-06-23 | — | — | CN | claimed |
| US-20260008784-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES | VASTHERA CO LTD (KR) | 2026-01-08 | — | — | US | disclosed |
| US-20250376443-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION (US) | 2025-12-11 | — | — | US | disclosed |
| US-20250368604-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION (US) | 2025-12-04 | — | — | US | disclosed |
| EP-4547673-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR MEDICAL USE FOR THE TREATMENT OR PREVENTION OF VASCULAR DISEASES | VASTHERA Co. Ltd. (KR) | 2025-05-07 | — | — | EP | disclosed |
| US-20250129020-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION (US) | 2025-04-24 | — | — | US | disclosed |
| CN-119403810-A | Compounds, pharmaceutical compositions containing them and their medical use for the treatment or prevention of vascular diseases | 瓦斯塞拉股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-119350433-A | MASP-2 inhibitors and methods of use | 奥默罗斯公司 | 2025-01-24 | — | — | CN | disclosed |
| US-12195427-B2 | MASP-2 inhibitors and methods of use | OMEROS CORPORATION (US) | 2025-01-14 | — | — | US | disclosed |
| CN-112867706-B | MASP-2 inhibitors and methods of use | 奥默罗斯公司 | 2024-11-15 | — | — | CN | disclosed |
| US-20070213329-A1 | Sulphones which modulate the action of gammasecretase | MERCK SHARP & DOHME (UK) LIMITED (GB) | 2007-09-13 | — | — | US | disclosed |
| WO-2007014409-A1 | PLEUROMUTILIN DERIVATIVES USEFUL AS ANTIBACTERIALS | NABRIVA THERAPEUTICS FORSCHUNGS GMBH (AT) | 2007-02-08 | — | — | WO | disclosed |
| US-20070010489-A1 | Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds | GILEAD SCIENCES, INC. | 2007-01-11 | — | — | US | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |
| EP-0667854-B1 | PEPTIDYL ACTIVATED KETONE INHIBITORS CONTAINING NATURAL AND UNNATURAL PEPTIDE SEQUENCES | PROTOTEK INC (US) | 1999-06-02 | — | — | EP | disclosed |
| EP-0667854-A1 | PEPTIDYL ACTIVATED KETONE INHIBITORS CONTAINING NATURAL AND UNNATURAL PEPTIDE SEQUENCES | PROTOTEK, INC., (US) | 1995-08-23 | — | — | EP | disclosed |
| EP-0667854-A4 | PEPTIDYL ACTIVATED KETONE INHIBITORS CONTAINING NATURAL AND UNNATURAL PEPTIDE SEQUENCES. | PROTOTEK INC (US) | 1995-07-04 | — | — | EP | disclosed |
| US-5374623-A | Cysteine protease inhibitors effective for in vivo use | PROTOTEK, INC. (US) | 1994-12-20 | — | — | US | disclosed |
| WO-1994004172-A1 | PEPTIDYL ACTIVATED KETONE INHIBITORS CONTAINING NATURAL AND UNNATURAL PEPTIDE SEQUENCES | PROTOTEK, INC. (US) | 1994-03-03 | — | — | WO | disclosed |
| US-4723031-A | Processes for synthesizing substituted and unsubstituted aminoacetate esters | CHEVRON RESEARCH COMPANY (US) | 1988-02-02 | — | — | US | disclosed |